| Literature DB >> 31445112 |
Abstract
Fewer than 20% of Americans with opioid use disorder receive empirically-supported treatment. There is a critical need for innovative approaches to support expansion of evidence-based opioid treatment, particularly in rural geographic areas so impacted by the current opioid public health crisis. Doing so will require more diverse pathways into treatment, novel pharmacological tools, improved integration and efficiency among treatment modalities, and harm reduction when treatment is not available. In this invited commentary, we review exciting recent efforts to accomplish these aims as well as offer additional considerations for future clinical and research efforts to increase the availability of treatment for opioid use disorder.Entities:
Keywords: Agonist maintenance; Buprenorphine; Methadone; Opioid use disorder; Treatment
Mesh:
Substances:
Year: 2019 PMID: 31445112 PMCID: PMC7081076 DOI: 10.1016/j.ypmed.2019.105818
Source DB: PubMed Journal: Prev Med ISSN: 0091-7435 Impact factor: 4.018